This Multidistrict Litigation ("MDL") was created by Order of the United States Judicial Panel on Multidistrict Litigation ("MDL Panel") on April 1, 2013. The typical case involves claims by a plaintiff from anywhere in the United States against defendant McNeil-PPC, Inc., and many other defendants as well.

In its April 1, 2013 Order, the MDL Panel found that the actions in this MDL "involve common questions of fact, and that centralization in the Eastern District of Pennsylvania will serve the convenience of the parties and witnesses and promote the just and efficient conduct of the litigation."

The MDL Panel noted that the actions "involve allegations that over-the-counter ("OTC") acetaminophen containing products that are marked and sold under its TYLENOL® brand-name caused liver damage, including liver failure, even when taken as directed." McNeill-PPC, Inc. and the other defendants deny these allegations.

The Panel further found that "centralization will eliminate duplicate discovery; prevent inconsistent pretrial rulings; and conserve the resources of the parties, their counsel and the judiciary."

The information provided through this site is not intended to be nor should it be considered legal advice.